|
Login
Directory:
Add Company
| Your company can benefit
from enhanced listings. Questions? Read our FAQ
first. |
Personalized notification service and newsletter info
| Subscribe (free) to get notified
of new additions. |
Learn more About us and about our Services
Contact us
|
New
service
|
|
New Supply services for API and finished products
Concerns: service Released on: 15-Jan-2002 Type:
- API / chemicals
- Curative
- FP (finished products)
- OTC (over the counter drugs)
- Pharmaceuticals / Therapeutics
- Phyto
- Nutritionals / Vitamins
- Prescription drugs (Rx)
- Preventive
Therapeutic target:
- Allergy
- Arthritis / Rheumato
- Asthma
- Cardiovascular
- Central nervous system
- Dermatology
- Cough / Cold
- Gastrointestinal
- Infectious Diseases
- Neurology
- Pain
- Respiratory Medicine
- Tonics
Concerns the following market: - Belgium - Netherlands - Luxembourg - France - Germany
Other: Contact us for coverage in your country |
|
Full Description: New Supply services, to fit anywhere into the process: - along with our licensing opportunities - integrated into the development process - as a stand-alone service for API and finished products
- Our supply organization and Quality Control of finished products and API targets competitive prices: Over the years PharmaRegistrations has build an in-depth knowledge and experience with the pharmaceutical business environment. Transfer of technology to suitable contract manufacturers are negotiated with EU-GMP compliant pharmaceutical companies with the goal to offer lower cost generic and OTC pharmaceutical products.
- Full guidance through technical and regulatory support: Transfer and quality will be assured after prior validations according to EU-guidelines for variation on the Manufacturing Site. Batch-to-batch QC, prior to supply of industrial batches to EU, are under full control of our EU-experts and in accordance with current EU-guidelines. Necessary variations - type I or II - will be supported by our Regulatory experts.
This supply chain QC and organization includes, combined or separately the API.
Contact for this news release: Lieve Vermassen
|
Suggestion box |
Disclaimer | Privacy
Policy | Rules & Regulations
Copyright© Cofidei, Inc. Page last modified: 30-Sep-2002.
|